A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1)
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of ALN-AGT01 on systolic and diastolic
blood pressure and to characterize the pharmacodynamic (PD) effects and safety of ALN-AGT01.